OraSure Technologies | OSUR - Operating Profit


OraSure Technologies reported $-13.59M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Agilent USD 399M 46M Mar/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Bio-Rad Laboratories USD 53.9M 10M Dec/2025
Bruker USD 10.2M 66.1M Mar/2026
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Danaher USD 1.34B 158M Mar/2026
Dentsply International USD 32M 506M Mar/2026
Dexcom USD 255.3M 67.7M Mar/2026
Illumina USD 239M 17M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Mettler Toledo International USD 233.93M 118M Mar/2026
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD -31.8M 5.5M Mar/2026
Repligen USD 19.98M 13K Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
STAAR Surgical USD 17.4M 28.34M Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Trinity Biotech USD -509K 6.27M Sep/2025
Waters USD 148M 122.52M Mar/2026